Clinical, scientific, and policy experts gather every several years to review and revise the recommendations that guide how clinicians around the world assess and manage patients with blood fat ...

Hello, and welcome to Wave Life Sciences Positive Interim Phase I Clinical Data from INLIGHT Trial of WVE-007 for Obesity Call. [Operator Instructions] Also, as a reminder, this conference is being ...

WAVE Life Sciences (NASDAQ:WVE) highlighted positive interim data from the ongoing Phase 1 INLIGHT trial of WVE-007, a GalNAc ...

Currently, the oral weight loss drug sector is led by competitor Novo Nordisk. Eli Lilly’s candidate, however, presents distinct competitive edges. The daily pill eliminates strict fasting ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31, 2025, and ...

QSIVA offers clinically meaningful weight loss supported by a well-established safety profile, now available at a reduced price across Nordics and Poland AMSTERDAM, March 25, 2026 (GLOBE NEWSWIRE) ...

Novo Nordisk A/S (NYSE:NVO) and The United Laboratories International Holdings Limited announced Wednesday that their jointly developed drug UBT251 demonstrated significant improvements in blood sugar ...

Viking Therapeutics receives continued rating support from multiple research firms, reinforcing market visibility.

Dietary supplements for diabetes are generally not recommended, but some research shows the benefits of using them to manage blood sugar. Learn the effects of cinnamon, magnesium, and more.

With prized genetics and an artisanal approach, Jiyu American Wagyu is introducing Iowa City to the world stage with some of ...

Knowing your personal risk of developing heart disease and managing your cholesterol early through healthy habits, regular ...

The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high ...